Journal profile · Biochemistry & Molecular Biology
Trends in Molecular Medicine
ISSN 1471-4914 · eISSN 1471-499X · Elsevier Ltd · ENGLAND · Monthly · Founded 2001
Trends in Molecular Medicine: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 17.75; hybrid open access; APC about USD 7,030; median 69 days to acceptance (105 articles, last 24 months); community-reported acceptance: mostly invited papers; 142 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Trends in Molecular Medicine is published by Elsevier Ltd and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Diverse Scientific and Economic Studies, Human auditory perception and evaluation and Legal Cases and Commentary, together about 28.2% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Trends in Molecular Medicine objective is to provide concise and contextualized views on the latest research moving biomedical science closer to improved diagnosis, treatment, and prevention of human diseases. As such, TMM is dedicated to research disciplines at the interface between basic biology and clinical research. Articles cover new concepts in mechanisms of human biology and pathology with clear implications for diagnostics and therapy. Bridging bench and bedside, reviews published in TMM have clear implications for human health and disease and discuss not only preclinical studies but also research conducted on patient samples, first-in-man studies, and patient-enrolled trials. The major themes covered in TMM in include:Disease mechanismsTools and technologiesDiagnosticsTherapeuticsWe particularly seek articles that are relevant to more than one of these themes. The goal of TMM is to serve as platform for discussion, push the boundaries of traditional clinical or scientific categorization and forge new links between scientists and clinicians. TMM reviews and opinions serve as templates for future explorations in molecular medicine, and to inspire new directions of studies toward improving human health. The journal's focus is on publishing articles that are provocative and authoritative but also accessible to a broad audience.Furthermore 'medicine' involves a vital societal element; molecular interventions raise controversial ethical, legal and financial issues. TMM also publishes discussions concerning the clinical trial landscape, science policy and medical ethics.All these issues are addressed in TMM in a style that builds on 25 years' experience of publishing the Trends journals.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry & Molecular Biology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance14.1%
- Human auditory perception and evaluationEngineering8%
- Legal Cases and CommentaryMedicine6.2%
- Immune Cell Function and InteractionImmunology and Microbiology5.4%
- Legal case studies and regulationsSocial Sciences4.8%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology4.5%
- Immunotherapy and Immune ResponsesImmunology and Microbiology4.5%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Biochemistry & Molecular Biology | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 1 |
| Minor | Cell Biology | Zone 2 |
Top journal: yesReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Biochemistry & Molecular Biology | Zone 1 |
| Minor | Cell Biology | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 1 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
| Minor | Cell Biology | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 17.75LetPub ·
- Impact factor (publisher)
- 18.1Publisher website ·
- CiteScore 2026-06
- 24LetPub ·
- CiteScore (publisher)
- 24Publisher website ·
- SJR 2026-06
- 3.68LetPub ·
- SNIP 2026-06
- 2.9LetPub ·
- h-index
- 160LetPub ·
- h-index
- 242OpenAlex ·
- i10-index
- 2,028OpenAlex ·
- 2-year mean citedness
- 8.51OpenAlex ·
- Self-citation rate
- 0.6%LetPub ·
- Share of gold OA articles
- 31.13%LetPub ·
Volume
- Articles per year
- 74LetPub ·
Articles by year OpenAlex count · 3,230 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 107 | 34 | 79 |
| 2025 | 142 | 57 | 912 |
| 2024 | 185 | 85 | 2,702 |
| 2023 | 127 | 70 | 4,445 |
| 2022 | 142 | 80 | 5,157 |
| 2021 | 131 | 67 | 4,859 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
69 daysMedian, submission to acceptance · P25–P75 41 days – 103 days
- Acceptance to online
- median 23 days (105 articles)
- Submission to online
- median 98 days
- Sample
- 105 articles with submission and acceptance dates (282 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Mostly invited papersLetPub ·
- Submission to acceptance
- 95 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 7,030 / EUR 6,510 / GBP 5,630 / JPY 871,930 | — | — | |
| Publisher website | USD 7,030 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open Access
Article Publishing Charge (APC): USD 7,030 (excluding taxes). The amount you pay may be reduced during submission if applicable.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 2001
- ISSN
- 1471-4914
- Electronic ISSN
- 1471-499X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Trends in Molecular Medicine
What CAS zone is Trends in Molecular Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Trends in Molecular Medicine is in Zone 1 of Medicine, and in Zone 1 of the minor category Biochemistry & Molecular Biology / Medicine, Research & Experimental / Cell Biology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Trends in Molecular Medicine?
The latest impact factor listed by LetPub is 17.75; CiteScore 24, h-index 242.
How long does peer review take at Trends in Molecular Medicine?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 69 days (interquartile range 41–103 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Mostly invited papers”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Trends in Molecular Medicine?
According to LetPub and DOAJ records, Trends in Molecular Medicine is indexed in SCIE and Scopus.
Is Trends in Molecular Medicine open access, and what is the APC?
Trends in Molecular Medicine is a hybrid journal. For open-access publication: APC about USD 7,030.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .